{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:20:19Z","timestamp":1781551219795,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["F.4-28\/2015\/CAS-II (SAP-II)"],"award-info":[{"award-number":["F.4-28\/2015\/CAS-II (SAP-II)"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["3643\/NET-DEC.2012"],"award-info":[{"award-number":["3643\/NET-DEC.2012"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00430-022-00754-5","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:30:11Z","timestamp":1668760211000},"page":"35-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["In vitro and in vivo therapeutic antileishmanial potential of ellagic acid against Leishmania donovani in murine model"],"prefix":"10.1007","volume":"212","author":[{"given":"Poonam","family":"Keshav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Kumar","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-7950","authenticated-orcid":false,"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"754_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0006052","volume":"11","author":"A Ponte-Sucre","year":"2017","unstructured":"Ponte-Sucre A, Gamarro F, Dujardin JC et al (2017) Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Negl Trop Dis 11:1\u201324","journal-title":"PLoS Negl Trop Dis"},{"key":"754_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104947","volume":"93","author":"DK Goyal","year":"2021","unstructured":"Goyal DK, Keshav P, Kaur S (2021) Adjuvant effects of TLR agonist gardiquimod admixed with Leishmania vaccine in mice model of visceral leishmaniasis. Infect Genet Evol 93:104947","journal-title":"Infect Genet Evol"},{"key":"754_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.resmic.2003.12.001","volume":"155","author":"RR Mendon\u00e7a-Filho","year":"2004","unstructured":"Mendon\u00e7a-Filho RR, Rodrigues IA, Alviano DS et al (2004) Leishmanicidal activity of polyphenolic-rich extract from husk fiber of Cocos nucifera Linn. (Palmae). Res Microbiol 155:136\u2013143","journal-title":"Res Microbiol"},{"key":"754_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pt.2019.10.005","volume":"36","author":"AV Ibarra-Meneses","year":"2020","unstructured":"Ibarra-Meneses AV, Moreno J, Carrillo E (2020) New strategies and biomarkers for the control of visceral leishmaniasis. Trends Parasitol 36:29\u201338","journal-title":"Trends Parasitol"},{"key":"754_CR5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s12639-021-01388-9","volume":"45","author":"P Keshav","year":"2021","unstructured":"Keshav P, Goyal DK, Kaur S (2021) GC\u2013MS screening and antiparasitic action of Putranjiva roxburghii leaves against sensitive and resistant strains of Leishmania donovani. J Parasit Dis 45:1002\u20131013","journal-title":"J Parasit Dis"},{"key":"754_CR6","doi-asserted-by":"publisher","first-page":"6931497","DOI":"10.1155\/2017\/6931497","volume":"2017","author":"T Wijerathna","year":"2017","unstructured":"Wijerathna T, Gunathilaka N, Gunawardana K, Rodrigo W (2017) Potential challenges of controlling leishmaniasis in Sri Lanka at a disease outbreak. Biomed Res Int 2017:6931497","journal-title":"Biomed Res Int"},{"key":"754_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005529","volume":"11","author":"S Kamhawi","year":"2017","unstructured":"Kamhawi S (2017) The yin and yang of leishmaniasis control. PLoS Negl Trop Dis 11:1\u20136","journal-title":"PLoS Negl Trop Dis"},{"key":"754_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104733","volume":"151","author":"DK Goyal","year":"2021","unstructured":"Goyal DK, Keshav P, Kaur S (2021) Adjuvanted vaccines driven protection against visceral infection in BALB\/c mice by Leishmania donovani. Microb Pathog 151:104733","journal-title":"Microb Pathog"},{"key":"754_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/0974-777X.62887","volume":"2","author":"J Chakravarty","year":"2010","unstructured":"Chakravarty J, Sundar S (2010) Drug resistance in leishmaniasis. J Glob Infect Dis 2:167","journal-title":"J Glob Infect Dis"},{"key":"754_CR10","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1128\/JCM.00173-11","volume":"49","author":"P Srivastava","year":"2011","unstructured":"Srivastava P, Prajapati VK, Rai M, Sundar S (2011) Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic. J Clin Microbiol 49:3088\u20133091","journal-title":"J Clin Microbiol"},{"key":"754_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-017-1969-z","volume":"10","author":"S Srivastava","year":"2017","unstructured":"Srivastava S, Mishra J, Gupta AK et al (2017) Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India. Parasit Vectors 10:1\u201311","journal-title":"Parasit Vectors"},{"key":"754_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.4269\/ajtmh.18-0949","volume":"101","author":"JBT Carnielli","year":"2019","unstructured":"Carnielli JBT, Monti-Rocha R, Costa DL et al (2019) Natural resistance of Leishmania infantum to miltefosine contributes to the low efficacy in the treatment of visceral leishmaniasis in Brazil. Am J Trop Med Hyg 101:789\u2013794","journal-title":"Am J Trop Med Hyg"},{"key":"754_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imbio.2021.152057","volume":"226","author":"DK Goyal","year":"2021","unstructured":"Goyal DK, Keshav P, Kaur S (2021) Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB\/c mice. Immunobiology 226:1\u201315","journal-title":"Immunobiology"},{"key":"754_CR14","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1007\/s11756-021-00897-5","volume":"76","author":"DK Goyal","year":"2021","unstructured":"Goyal DK, Keshav P, Kaur S (2021) Antiparasitic potential of Indian honey bee glue against strains of Leishmania donovani sensitive and resistant to synthetic antileishmanial. Biologia (Bratisl) 76:3841\u20133854","journal-title":"Biologia (Bratisl)"},{"key":"754_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pim.12719","volume":"42","author":"N Majumder","year":"2020","unstructured":"Majumder N, Ganguly S, Ghosh AK et al (2020) Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro. Parasite Immunol 42:1\u201312","journal-title":"Parasite Immunol"},{"key":"754_CR16","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/jac\/dks159","volume":"67","author":"S Bhattacharjee","year":"2012","unstructured":"Bhattacharjee S, Bhattacharjee A, Majumder S et al (2012) Glycyrrhizic acid suppresses cox-2-mediated anti-inflammatory responses during Leishmania donovani infection. J Antimicrob Chemother 67:1905\u20131914","journal-title":"J Antimicrob Chemother"},{"key":"754_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu10111756","volume":"10","author":"C Ceci","year":"2018","unstructured":"Ceci C, Lacal PM, Tentori L et al (2018) Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid. Nutrients 10:1\u201323","journal-title":"Nutrients"},{"key":"754_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1472-8206.2008.00618.x","volume":"22","author":"C Girish","year":"2008","unstructured":"Girish C, Pradhan SC (2008) Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin. Fundam Clin Pharmacol 22:623\u2013632","journal-title":"Fundam Clin Pharmacol"},{"key":"754_CR19","first-page":"92","volume":"11","author":"HM Zhang","year":"2014","unstructured":"Zhang HM, Zhao L, Li H et al (2014) Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol Med 11:92\u2013100","journal-title":"Cancer Biol Med"},{"key":"754_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109845","volume":"125","author":"Z Lin","year":"2020","unstructured":"Lin Z, Lin C, Fu C et al (2020) The protective effect of ellagic acid (EA) in osteoarthritis: an in vitro and in vivo study. Biomed Pharmacother 125:109845","journal-title":"Biomed Pharmacother"},{"key":"754_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00210-017-1387-y","volume":"390","author":"MMM Alves","year":"2017","unstructured":"Alves MMM, Brito LM, Souza AC et al (2017) Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania major. Naunyn Schmiedebergs Arch Pharmacol 390:893\u2013903","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"754_CR22","first-page":"e00807","volume":"64","author":"MM de Moraes Alves","year":"2020","unstructured":"de Moraes Alves MM, Arcanjo DDR, Figueiredo KA et al (2020) Gallic and ellagic acids are promising adjuvants to conventional amphotericin b for the treatment of cutaneous leishmaniasis. Antimicrob Agents Chemother 64:e00807-e820","journal-title":"Antimicrob Agents Chemother"},{"key":"754_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.exppara.2010.10.014","volume":"127","author":"SK Singh","year":"2011","unstructured":"Singh SK, Bimal S, Narayan S et al (2011) Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India. Exp Parasitol 127:552\u2013558","journal-title":"Exp Parasitol"},{"key":"754_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.parint.2013.01.007","volume":"62","author":"S Chandrasekaran","year":"2013","unstructured":"Chandrasekaran S, Dayakar A, Veronica J et al (2013) An in vitro study of apoptotic like death in Leishmania donovani promastigotes by with anolides. Parasitol Int 62:253\u2013261","journal-title":"Parasitol Int"},{"key":"754_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.indcrop.2015.09.049","volume":"77","author":"R Essid","year":"2015","unstructured":"Essid R, Rahali FZ, Msaada K et al (2015) Antileishmanial and cytotoxic potential of essential oils from medicinal plants in Northern Tunisia. Ind Crops Prod 77:795\u2013802","journal-title":"Ind Crops Prod"},{"key":"754_CR26","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00436-008-1150-x","volume":"103","author":"S Kaur","year":"2008","unstructured":"Kaur S, Kaur T, Garg N et al (2008) Effect of dose and route of inoculation on the generation of CD4 + Th1\/Th2 type of immune response in murine visceral leishmaniasis. Parasitol Res 103:1413\u20131419","journal-title":"Parasitol Res"},{"key":"754_CR27","first-page":"119","volume":"30","author":"DJ Bradley","year":"1977","unstructured":"Bradley DJ, Kirkley J (1977) Regulation of Leishmania populations within the host. I. The variable course of Leishmania donovani infections in mice. Clin Exp Immunol 30:119\u2013129","journal-title":"Clin Exp Immunol"},{"key":"754_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0094596","volume":"9","author":"R Shivahare","year":"2014","unstructured":"Shivahare R, Vishwakarma P, Parmar N et al (2014) Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis. PLoS ONE 9:1\u201312","journal-title":"PLoS ONE"},{"key":"754_CR29","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/jac\/dkr575","volume":"67","author":"SK Bhaumik","year":"2012","unstructured":"Bhaumik SK, Paul J, Naskar K et al (2012) Asiaticoside induces tumour-necrosis-factor-\u03b1-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains. J Antimicrob Chemother 67:910\u2013920","journal-title":"J Antimicrob Chemother"},{"key":"754_CR30","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.intimp.2006.05.002","volume":"6","author":"A Gupta","year":"2006","unstructured":"Gupta A, Khajuria A, Singh J et al (2006) Immunomodulatory activity of biopolymeric fraction RLJ-NE-205 from Picrorhiza kurroa. Int Immunopharmacol 6:1543\u20131549","journal-title":"Int Immunopharmacol"},{"key":"754_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105021","volume":"158","author":"DK Goyal","year":"2021","unstructured":"Goyal DK, Keshav P, Kaur S (2021) Potential of TLR agonist as an adjuvant in leishmania vaccine against visceral leishmaniasis in BALB\/c mice. Microb Pathog 158:105021","journal-title":"Microb Pathog"},{"key":"754_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00296","volume":"5","author":"OP Singh","year":"2014","unstructured":"Singh OP, Sundar S (2014) Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects. Front Immunol 5:1\u20139","journal-title":"Front Immunol"},{"key":"754_CR33","first-page":"269","volume":"10","author":"L Monzote","year":"2016","unstructured":"Monzote L, Perera C\u00f3rdova WH, Garc\u00eda M et al (2016) In-vitro and in-vivo activities of phenolic compounds against cutaneous leishmaniasis. Rec Nat Prod 10:269\u2013276","journal-title":"Rec Nat Prod"},{"key":"754_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0007206","volume":"13","author":"CA Antwi","year":"2019","unstructured":"Antwi CA, Amisigo CM, Adjimani JP, Gwira TM (2019) In vitro activity and mode of action of phenolic compounds on Leishmania donovani. PLoS Negl Trop Dis 13:1\u201322","journal-title":"PLoS Negl Trop Dis"},{"key":"754_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003321","volume":"9","author":"M Islamuddin","year":"2015","unstructured":"Islamuddin M, Chouhan G, Farooque A et al (2015) Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis. PLoS Negl Trop Dis 9:e3321","journal-title":"PLoS Negl Trop Dis"},{"key":"754_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.exppara.2010.02.011","volume":"125","author":"J Kaur","year":"2010","unstructured":"Kaur J, Singh N, Singh BK et al (2010) Leishmania donovani: oral therapy with glycosyl 1,4-dihydropyridine analogue showing apoptosis like phenotypes targeting pteridine reductase 1 in intracellular amastigotes. Exp Parasitol 125:310\u2013314","journal-title":"Exp Parasitol"},{"key":"754_CR37","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/10715760903186124","volume":"43","author":"P Saha","year":"2009","unstructured":"Saha P, Sen R, Hariharan C et al (2009) Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes. Free Radic Res 43:1101\u20131110","journal-title":"Free Radic Res"},{"key":"754_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/306705","volume":"2013","author":"YC Chung","year":"2013","unstructured":"Chung YC, Lu LC, Tsai MH et al (2013) The inhibitory effect of ellagic acid on cell growth of ovarian carcinoma cells. Evid Based Complement Altern Med 2013:306705","journal-title":"Evid Based Complement Altern Med"},{"key":"754_CR39","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3892\/ijo.2015.2870","volume":"46","author":"HS Chen","year":"2015","unstructured":"Chen HS, Bai MH, Zhang T et al (2015) Ellagic acid induces cell cycle arrest and apoptosis through TGF-\u03b2\/Smad3 signaling pathway in human breast cancer MCF-7 cells. Int J Oncol 46:1730\u20131738","journal-title":"Int J Oncol"},{"key":"754_CR40","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3892\/or.2020.7617","volume":"44","author":"J Zhao","year":"2020","unstructured":"Zhao J, Li G, Wei J et al (2020) Ellagic acid induces cell cycle arrest and apoptosis via the TGF-\u03b21\/Smad3 signaling pathway in human colon cancer HCT.116 cells. Oncol Rep 44:768\u2013776","journal-title":"Oncol Rep"},{"key":"754_CR41","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3389\/fmicb.2015.01368","volume":"6","author":"G Chouhan","year":"2015","unstructured":"Chouhan G, Islamuddin M, Want MY, Ozbak HA, Hemeg HA, Sahal D, Afrin F (2015) Leishmanicidal activity of Piper nigrum bioactive fractions is interceded via apoptosis in vitro and substantiated by Th1 immunostimulatory potential in vivo. Front Microbiol 6:1368","journal-title":"Front Microbiol"},{"key":"754_CR42","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1128\/AAC.00030-11","volume":"56","author":"B Purkait","year":"2012","unstructured":"Purkait B, Kumar A, Nandi N et al (2012) Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother 56:1031\u20131041","journal-title":"Antimicrob Agents Chemother"},{"key":"754_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.parint.2009.10.006","volume":"59","author":"S Kaur","year":"2010","unstructured":"Kaur S, Sachdeva H, Dhuria S et al (2010) Antileishmanial effect of cisplatin against murine visceral leishmaniasis. Parasitol Int 59:62\u201369","journal-title":"Parasitol Int"},{"key":"754_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaim.2017.10.009","volume":"11","author":"R Kaur","year":"2020","unstructured":"Kaur R, Kaur S (2020) Protective efficacy of Chlorophytum borivilianum root extract against murine visceral leishmaniasis by immunomodulating the host responses. J Ayurveda Integr Med 11:53\u201361","journal-title":"J Ayurveda Integr Med"},{"key":"754_CR45","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1128\/AAC.01175-08","volume":"53","author":"PN Soh","year":"2009","unstructured":"Soh PN, Witkowski B, Olagnier D et al (2009) In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob Agents Chemother 53:1100\u20131106","journal-title":"Antimicrob Agents Chemother"},{"key":"754_CR46","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/ptr.5869","volume":"31","author":"M Garc\u00eda","year":"2017","unstructured":"Garc\u00eda M, Scull R, Satyal P et al (2017) Chemical characterization, antileishmanial activity, and cytotoxicity effects of the essential oil from leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae). Phyther Res 31:1419\u20131426","journal-title":"Phyther Res"},{"key":"754_CR47","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s00436-014-3954-1","volume":"113","author":"E Montrieux","year":"2014","unstructured":"Montrieux E, Perera WH, Garc\u00eda M et al (2014) In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis. Parasitol Res 113:2925\u20132932","journal-title":"Parasitol Res"},{"key":"754_CR48","first-page":"1","volume":"13","author":"HA Ozbak","year":"2019","unstructured":"Ozbak HA, Hemeg HA, Afrin F et al (2019) Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo. PLoS Negl Trop Dis 13:1\u201328","journal-title":"PLoS Negl Trop Dis"},{"key":"754_CR49","doi-asserted-by":"publisher","first-page":"01943","DOI":"10.3389\/fimmu.2017.01943","volume":"8","author":"W Adriaensen","year":"2018","unstructured":"Adriaensen W, Dorlo TPC, Vanham G et al (2018) Immunomodulatory therapy of visceral leishmaniasis in human immunodeficiency virus-coinfected patients. Front Immunol 8:01943","journal-title":"Front Immunol"},{"key":"754_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/intimm\/dxx075","volume":"30","author":"M Rossi","year":"2018","unstructured":"Rossi M, Fasel N (2018) How to master the host immune system? Leishmania parasites have the solutions! Int Immunol 30:103\u2013111","journal-title":"Int Immunol"},{"key":"754_CR51","doi-asserted-by":"publisher","first-page":"2496713","DOI":"10.1155\/2020\/2496713","volume":"2020","author":"T Dubie","year":"2020","unstructured":"Dubie T, Mohammed Y (2020) Review on the role of host immune response in protection and immunopathogenesis during cutaneous leishmaniasis infection. J Immunol Res 2020:2496713","journal-title":"J Immunol Res"},{"key":"754_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-407679-2.00005-3","volume":"82","author":"G Gupta","year":"2013","unstructured":"Gupta G, Oghumu S, Satoskar AR (2013) Mechanisms of immune evasion in leishmaniasis. Adv Appl Microbiol 82:155\u2013184","journal-title":"Adv Appl Microbiol"},{"key":"754_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12879-014-0653-6","volume":"14","author":"H Kaushal","year":"2014","unstructured":"Kaushal H, Bras-Gon\u00e7alves R, Negi NS et al (2014) Role of CD8+ T cells in protection against Leishmania donovani infection in healed visceral leishmaniasis individuals. BMC Infect Dis 14:8\u201314","journal-title":"BMC Infect Dis"},{"key":"754_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","volume":"3","author":"S St\u00e4ger","year":"2012","unstructured":"St\u00e4ger S, Rafati S (2012) CD8+ T cells in leishmania infections: friends or foes? Front Immunol 3:5","journal-title":"Front Immunol"},{"key":"754_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-015-0788-3","volume":"8","author":"G Chouhan","year":"2015","unstructured":"Chouhan G, Islamuddin M, Want MY et al (2015) Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo. Parasit Vectors 8:1\u201324","journal-title":"Parasit Vectors"},{"key":"754_CR56","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.intimp.2012.02.001","volume":"12","author":"S Abid","year":"2012","unstructured":"Abid S, Khajuria A, Parvaiz Q et al (2012) Immunomodulatory studies of a bioactive fraction from the fruit of Prunus cerasus in BALB\/c mice. Int Immunopharmacol 12:626\u2013634","journal-title":"Int Immunopharmacol"},{"key":"754_CR57","first-page":"2961","volume":"9","author":"W Ahmad","year":"2015","unstructured":"Ahmad W, Jantan I, Kumolosasi E, Bukhari SNA (2015) Immunostimulatory effects of the standardized extract of Tinospora crispa on innate immune responses in Wistar Kyoto rats. Drug Des Dev Ther 9:2961\u20132973","journal-title":"Drug Des Dev Ther"},{"key":"754_CR58","first-page":"238","volume":"119","author":"A Awasthi","year":"2004","unstructured":"Awasthi A, Mathur RK, Saha B (2004) Immune response to leishmania infection. Indian J Med Res 119:238\u2013258","journal-title":"Indian J Med Res"},{"key":"754_CR59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jac\/dkn479","volume":"63","author":"S Bhattacharjee","year":"2009","unstructured":"Bhattacharjee S, Gupta G, Bhattacharya P et al (2009) Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity. J Antimicrob Chemother 63:317\u2013324","journal-title":"J Antimicrob Chemother"},{"key":"754_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms8081201","volume":"8","author":"NM Ikeogu","year":"2020","unstructured":"Ikeogu NM, Akaluka GN, Edechi CA et al (2020) Leishmania immunity: Advancing immunotherapy and vaccine development. Microorganisms 8:1\u201321","journal-title":"Microorganisms"},{"key":"754_CR61","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1084\/jem.189.4.741","volume":"189","author":"BHW Murray","year":"1999","unstructured":"Murray BHW, Nathan CF (1999) Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189:741\u2013746","journal-title":"J Exp Med"},{"key":"754_CR62","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1006\/cyto.2000.0694","volume":"12","author":"O Bacellar","year":"2000","unstructured":"Bacellar O, D\u2019Oliveira A, Jer\u00f4nimo S, Carvalho EM (2000) IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12:1228\u20131231","journal-title":"Cytokine"},{"key":"754_CR63","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.phytochem.2005.01.011","volume":"66","author":"H Kolodziej","year":"2005","unstructured":"Kolodziej H, Kiderlen AF (2005) Antileishmanial activity and immune modulatory effects of tannins and related compounds on leishmania parasitised RAW 264.7 cells. Phytochemistry 66:2056\u20132071","journal-title":"Phytochemistry"},{"key":"754_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005011","volume":"10","author":"M Islamuddin","year":"2016","unstructured":"Islamuddin M, Chouhan G, Want MY et al (2016) Immunotherapeutic potential of eugenol emulsion in experimental visceral leishmaniasis. PLoS Negl Trop Dis 10:1\u201323","journal-title":"PLoS Negl Trop Dis"},{"key":"754_CR65","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10875-010-9502-6","volume":"31","author":"N Hosseini","year":"2011","unstructured":"Hosseini N, Abolhassani M (2011) Immunomodulatory properties of borage (Echium amoenum) on BALB\/c mice infected with leishmania major. J Clin Immunol 31:465\u2013471","journal-title":"J Clin Immunol"},{"key":"754_CR66","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/cmi.2010.24","volume":"7","author":"RI Nurieva","year":"2010","unstructured":"Nurieva RI, Chung Y (2010) Understanding the development and function of T follicular helper cells. Cell Mol Immunol 7:190\u2013197","journal-title":"Cell Mol Immunol"},{"key":"754_CR67","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s00436-013-3387-2","volume":"112","author":"H Sachdeva","year":"2013","unstructured":"Sachdeva H, Sehgal R, Kaur S (2013) Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis. Parasitol Res 112:2269\u20132280","journal-title":"Parasitol Res"},{"key":"754_CR68","first-page":"547","volume":"47","author":"HIA El","year":"1994","unstructured":"El HIA, Hashim FA, El TIA, Homeida M (1994) Liver morphology and function in visceral leishmaniasis (Kala-azar). J Hepatol 47:547\u2013551","journal-title":"J Hepatol"},{"key":"754_CR69","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2165\/00002018-199005020-00003","volume":"5","author":"R Sabra","year":"1990","unstructured":"Sabra R, Branch RA (1990) Amphotericin B nephrotoxicity. Drug Saf 5:94\u2013108","journal-title":"Drug Saf"},{"key":"754_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jphs.2020.01.007","volume":"143","author":"NF Abdelkader","year":"2020","unstructured":"Abdelkader NF, Elyamany M, Gad AM et al (2020) Ellagic acid attenuates liver toxicity induced by valproic acid in rats. J Pharmacol Sci 143:23\u201329","journal-title":"J Pharmacol Sci"},{"key":"754_CR71","first-page":"299","volume":"17","author":"N Al-Kharusi","year":"2013","unstructured":"Al-Kharusi N, Babiker HA, Al-Salam S et al (2013) Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent study. Eur Rev Med Pharmacol Sci 17:299\u2013310","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"754_CR72","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-981-13-8763-0_16","volume-title":"Oxidative stress in microbial diseases","author":"M Basu","year":"2019","unstructured":"Basu M, Das PK (2019) Role of reactive oxygen species in infection by the intracellular leishmania parasites. In: Chakraborti S, Chakraborti T, Chattopadhyay D, Shaha C (eds) Oxidative stress in microbial diseases. Springer, Singapore, pp 297\u2013311. https:\/\/doi.org\/10.1007\/978-981-13-8763-0_16"},{"key":"754_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03943-y","volume":"7","author":"S Roy","year":"2017","unstructured":"Roy S, Dutta D, Satyavarapu EM et al (2017) Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis. Sci Rep 7:1\u201316","journal-title":"Sci Rep"},{"key":"754_CR74","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/infdis\/jis771","volume":"207","author":"K Ghosh","year":"2013","unstructured":"Ghosh K, Sharma G, Saha A et al (2013) Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. J Infect Dis 207:1016\u20131025","journal-title":"J Infect Dis"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-022-00754-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-022-00754-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-022-00754-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T23:22:39Z","timestamp":1676330559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-022-00754-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1007\/s00430-022-00754-5","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"1 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethical clearance was acquired from the Institutional Animal Ethics Committee (IAEC) of the University with IAEC no. PU\/IAEC\/S\/14\/147.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors agreed the work to be published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}